Back to Results
First PageMeta Content



[Press Release] China Regenerative Medicine International Limited (Stock Code: 8158.HK) CRMI enters into a Strategic Framework Cooperation Agreement with Shanghai Lingang Songjiang High-tech Industrial Development Co.,
Add to Reading List

Document Date: 2018-01-16 05:55:47


Open Document

File Size: 372,42 KB

Share Result on Facebook